Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roniel Cabrera

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 30, 2009
Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patientsRoniel Cabrera, Miguel Ararat, Consuelo Soldevila-Pico, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 31, 2012
OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinomaXiangxuan Zhao, Changhai Tian, William M Puszyk, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
The natural history of hepatitis C cirrhosis after liver transplantationRoberto J Firpi, Virginia Clark, Consuelo Soldevila-Pico, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectDavid R Nelson, Zhengkun Tu, Consuelo Soldevila-Pico, et al.
Digestive Diseases and Sciences|October 3, 2009
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot studyRoberto J Firpi, Consuelo Soldevila-Pico, Giuseppe G Morelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2012
CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplantRoberto J Firpi, Huijia Dong, Virginia C Clark, et al.
Oncology Reports|February 22, 2013
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinomaRenumathy Dhanasekaran, Alan W Hemming, Ivan Zendejas, et al.
Digestive Diseases and Sciences|January 12, 2013
Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantationAnthony J Michaels, Renumathy Dhanasekaran, David P Foley, et al.
Medicine|December 17, 2021
Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical dataRahma S Mkuu, Elizabeth A Shenkman, Keith E Muller, et al.
Preventive Medicine Reports|March 3, 2023
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United StatesHaesuk Park, Carolyn Brown, Debbie L Wilson, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 30, 2009
Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patientsRoniel Cabrera, Miguel Ararat, Consuelo Soldevila-Pico, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 31, 2012
OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinomaXiangxuan Zhao, Changhai Tian, William M Puszyk, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
The natural history of hepatitis C cirrhosis after liver transplantationRoberto J Firpi, Virginia Clark, Consuelo Soldevila-Pico, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectDavid R Nelson, Zhengkun Tu, Consuelo Soldevila-Pico, et al.
Digestive Diseases and Sciences|October 3, 2009
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot studyRoberto J Firpi, Consuelo Soldevila-Pico, Giuseppe G Morelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2012
CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplantRoberto J Firpi, Huijia Dong, Virginia C Clark, et al.
Oncology Reports|February 22, 2013
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinomaRenumathy Dhanasekaran, Alan W Hemming, Ivan Zendejas, et al.
Digestive Diseases and Sciences|January 12, 2013
Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantationAnthony J Michaels, Renumathy Dhanasekaran, David P Foley, et al.
Medicine|December 17, 2021
Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical dataRahma S Mkuu, Elizabeth A Shenkman, Keith E Muller, et al.
Preventive Medicine Reports|March 3, 2023
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United StatesHaesuk Park, Carolyn Brown, Debbie L Wilson, et al.
Pageof 7